AU5953494A - Restoration of immunological function in asymptomatic hiv-positive patients - Google Patents

Restoration of immunological function in asymptomatic hiv-positive patients

Info

Publication number
AU5953494A
AU5953494A AU59534/94A AU5953494A AU5953494A AU 5953494 A AU5953494 A AU 5953494A AU 59534/94 A AU59534/94 A AU 59534/94A AU 5953494 A AU5953494 A AU 5953494A AU 5953494 A AU5953494 A AU 5953494A
Authority
AU
Australia
Prior art keywords
restoration
positive patients
immunological function
asymptomatic hiv
asymptomatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59534/94A
Inventor
Robert L. Coffman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU5953494A publication Critical patent/AU5953494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU59534/94A 1992-12-23 1993-12-21 Restoration of immunological function in asymptomatic hiv-positive patients Abandoned AU5953494A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99538492A 1992-12-23 1992-12-23
PCT/US1993/012292 WO1994014474A1 (en) 1992-12-23 1993-12-21 Restoration of immunological function in asymptomatic hiv-positive patients
US995384 2001-11-27

Publications (1)

Publication Number Publication Date
AU5953494A true AU5953494A (en) 1994-07-19

Family

ID=25541722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59534/94A Abandoned AU5953494A (en) 1992-12-23 1993-12-21 Restoration of immunological function in asymptomatic hiv-positive patients

Country Status (3)

Country Link
AU (1) AU5953494A (en)
MX (1) MX9307733A (en)
WO (1) WO1994014474A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123109A0 (en) * 1995-08-18 1998-09-24 Rentschler Biotech Gmbh Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection
US5908621A (en) 1995-11-02 1999-06-01 Schering Corporation Polyethylene glycol modified interferon therapy
AU7473096A (en) * 1995-11-02 1997-05-22 Schering Corporation Continuous low-dose cytokine infusion therapy
GB9702021D0 (en) * 1997-01-31 1997-03-19 Imperial College Medicaments
BR0108997A (en) * 2000-03-09 2003-06-03 Schering Corp Adjuvant Immune Therapy for HIV

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052579T3 (en) * 1986-10-22 1994-07-16 Schering Corp USE OF INTERFERON ALPHA HUMAN RECOMBINANT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT AIDS VIRUSES.

Also Published As

Publication number Publication date
MX9307733A (en) 1994-06-30
WO1994014474A1 (en) 1994-07-07

Similar Documents

Publication Publication Date Title
AU1163192A (en) Sanitary napkin
AU6882694A (en) Sanitary napkin
AU3480989A (en) Oral preparations
AU2470792A (en) Wheelchair
AU8737091A (en) Wheelchair
AU6417490A (en) Liposomal cleaner
AU2675988A (en) Surfactant inhibition of dental plaque
AU5072793A (en) Sanitary napkin
AU4488393A (en) Antacid
AU7252291A (en) Inhibition of human immunodeficiency virus -1 infectivity in human cells
AU3008089A (en) Silyl 2-amidoacetate and silyl 3-amidopropionate compositions
AU5803494A (en) Glass ionomer cement compositions and restorations
AU2769789A (en) Pool cleaner
AU2966392A (en) Transparent part and use thereof
AU4014193A (en) Chair
AU4514093A (en) Recombinant antibody against human interleukin-1
AU3502789A (en) Composition and use
AU5953494A (en) Restoration of immunological function in asymptomatic hiv-positive patients
AU5666994A (en) T-configured wheelchair
AU5737494A (en) Human thrombospondin-4
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
AU4024289A (en) Selenium-sulfur compositions and uses therefor
AU7837987A (en) Folding chair
AU7169494A (en) Peptides for use in induction of T cell activation against HIV-1
AU7684887A (en) Folding chair